Global Peptide Drug CDMO Market Growth (Status and Outlook) 2024-2030

The global Peptide Drug CDMO market size is predicted to grow from US$ 2700 million in 2024 to US$ 4904 million in 2030; it is expected to grow at a CAGR of 10.5% from 2024 to 2030.

Peptide CDMO refers to an organization that accepts commissions from pharmaceutical companies and engages in the development and production of peptide drugs. These organizations usually have advanced peptide synthesis, purification, analysis and other technologies, and can provide customers with one-stop services from peptide API synthesis, purification, structural identification to formulation development, clinical trials, etc.

As a unique drug compound, peptides are between small molecules and proteins, and are different in biochemistry and treatment. Peptides provide opportunities for therapeutic interventions that closely mimic natural pathways and play a major role in various physiological processes in the human body (including hormones, neurotransmitters) or in inflammatory responses. Peptide drugs have the characteristics of strong selectivity and rapid onset, and can be extracted naturally or synthesized artificially. With multiple advantages such as high purity and controllable quality, they have become popular drugs at present. The medical field is an important application market for peptide substances, and the market demand for peptide drugs is increasing. Based on the complexity and high-tech characteristics of peptide drug development, peptide development and production outsourcing services came into being, that is, peptide CDMO began to appear.

United States market for Peptide Drug CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Peptide Drug CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Peptide Drug CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Peptide Drug CDMO players cover Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “Peptide Drug CDMO Industry Forecast” looks at past sales and reviews total world Peptide Drug CDMO sales in 2023, providing a comprehensive analysis by region and market sector of projected Peptide Drug CDMO sales for 2024 through 2030. With Peptide Drug CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Drug CDMO industry.

This Insight Report provides a comprehensive analysis of the global Peptide Drug CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Drug CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Drug CDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Drug CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Drug CDMO.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Drug CDMO market by product type, application, key players and key regions and countries.

Segmentation by Type:
    APIs and Intermediates
    FDF

Segmentation by Application:
    Antineoplastic Drugs
    Geno-Urinary System and Sex Hormones
    Cardiovascular System Drugs
    Anti-Infective Drugs

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Bachem
    PolyPeptide
    CordenPharma
    AmbioPharm
    USV Peptides
    Thermofischer
    Bio Basic
    JPT
    Genscript
    Xinbang Pharma
    ScinoPharm
    SN Biopharm
    CBL
    Piramal Pharma
    CPC Scientific

List of Tables
 Table 1. Peptide Drug CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
 Table 2. Peptide Drug CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
 Table 3. Major Players of APIs and Intermediates
 Table 4. Major Players of FDF
 Table 5. Peptide Drug CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
 Table 6. Global Peptide Drug CDMO Market Size by Type (2019-2024) & ($ millions)
 Table 7. Global Peptide Drug CDMO Market Size Market Share by Type (2019-2024)
 Table 8. Peptide Drug CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
 Table 9. Global Peptide Drug CDMO Market Size by Application (2019-2024) & ($ millions)
 Table 10. Global Peptide Drug CDMO Market Size Market Share by Application (2019-2024)
 Table 11. Global Peptide Drug CDMO Revenue by Player (2019-2024) & ($ millions)
 Table 12. Global Peptide Drug CDMO Revenue Market Share by Player (2019-2024)
 Table 13. Peptide Drug CDMO Key Players Head office and Products Offered
 Table 14. Peptide Drug CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Peptide Drug CDMO Market Size by Region (2019-2024) & ($ millions)
 Table 18. Global Peptide Drug CDMO Market Size Market Share by Region (2019-2024)
 Table 19. Global Peptide Drug CDMO Revenue by Country/Region (2019-2024) & ($ millions)
 Table 20. Global Peptide Drug CDMO Revenue Market Share by Country/Region (2019-2024)
 Table 21. Americas Peptide Drug CDMO Market Size by Country (2019-2024) & ($ millions)
 Table 22. Americas Peptide Drug CDMO Market Size Market Share by Country (2019-2024)
 Table 23. Americas Peptide Drug CDMO Market Size by Type (2019-2024) & ($ millions)
 Table 24. Americas Peptide Drug CDMO Market Size Market Share by Type (2019-2024)
 Table 25. Americas Peptide Drug CDMO Market Size by Application (2019-2024) & ($ millions)
 Table 26. Americas Peptide Drug CDMO Market Size Market Share by Application (2019-2024)
 Table 27. APAC Peptide Drug CDMO Market Size by Region (2019-2024) & ($ millions)
 Table 28. APAC Peptide Drug CDMO Market Size Market Share by Region (2019-2024)
 Table 29. APAC Peptide Drug CDMO Market Size by Type (2019-2024) & ($ millions)
 Table 30. APAC Peptide Drug CDMO Market Size by Application (2019-2024) & ($ millions)
 Table 31. Europe Peptide Drug CDMO Market Size by Country (2019-2024) & ($ millions)
 Table 32. Europe Peptide Drug CDMO Market Size Market Share by Country (2019-2024)
 Table 33. Europe Peptide Drug CDMO Market Size by Type (2019-2024) & ($ millions)
 Table 34. Europe Peptide Drug CDMO Market Size by Application (2019-2024) & ($ millions)
 Table 35. Middle East & Africa Peptide Drug CDMO Market Size by Region (2019-2024) & ($ millions)
 Table 36. Middle East & Africa Peptide Drug CDMO Market Size by Type (2019-2024) & ($ millions)
 Table 37. Middle East & Africa Peptide Drug CDMO Market Size by Application (2019-2024) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Peptide Drug CDMO
 Table 39. Key Market Challenges & Risks of Peptide Drug CDMO
 Table 40. Key Industry Trends of Peptide Drug CDMO
 Table 41. Global Peptide Drug CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
 Table 42. Global Peptide Drug CDMO Market Size Market Share Forecast by Region (2025-2030)
 Table 43. Global Peptide Drug CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
 Table 44. Global Peptide Drug CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
 Table 45. Bachem Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 46. Bachem Peptide Drug CDMO Product Offered
 Table 47. Bachem Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 48. Bachem Main Business
 Table 49. Bachem Latest Developments
 Table 50. PolyPeptide Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 51. PolyPeptide Peptide Drug CDMO Product Offered
 Table 52. PolyPeptide Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 53. PolyPeptide Main Business
 Table 54. PolyPeptide Latest Developments
 Table 55. CordenPharma Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 56. CordenPharma Peptide Drug CDMO Product Offered
 Table 57. CordenPharma Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 58. CordenPharma Main Business
 Table 59. CordenPharma Latest Developments
 Table 60. AmbioPharm Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 61. AmbioPharm Peptide Drug CDMO Product Offered
 Table 62. AmbioPharm Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 63. AmbioPharm Main Business
 Table 64. AmbioPharm Latest Developments
 Table 65. USV Peptides Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 66. USV Peptides Peptide Drug CDMO Product Offered
 Table 67. USV Peptides Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 68. USV Peptides Main Business
 Table 69. USV Peptides Latest Developments
 Table 70. Thermofischer Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 71. Thermofischer Peptide Drug CDMO Product Offered
 Table 72. Thermofischer Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 73. Thermofischer Main Business
 Table 74. Thermofischer Latest Developments
 Table 75. Bio Basic Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 76. Bio Basic Peptide Drug CDMO Product Offered
 Table 77. Bio Basic Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 78. Bio Basic Main Business
 Table 79. Bio Basic Latest Developments
 Table 80. JPT Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 81. JPT Peptide Drug CDMO Product Offered
 Table 82. JPT Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 83. JPT Main Business
 Table 84. JPT Latest Developments
 Table 85. Genscript Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 86. Genscript Peptide Drug CDMO Product Offered
 Table 87. Genscript Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 88. Genscript Main Business
 Table 89. Genscript Latest Developments
 Table 90. Xinbang Pharma Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 91. Xinbang Pharma Peptide Drug CDMO Product Offered
 Table 92. Xinbang Pharma Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 93. Xinbang Pharma Main Business
 Table 94. Xinbang Pharma Latest Developments
 Table 95. ScinoPharm Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 96. ScinoPharm Peptide Drug CDMO Product Offered
 Table 97. ScinoPharm Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 98. ScinoPharm Main Business
 Table 99. ScinoPharm Latest Developments
 Table 100. SN Biopharm Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 101. SN Biopharm Peptide Drug CDMO Product Offered
 Table 102. SN Biopharm Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 103. SN Biopharm Main Business
 Table 104. SN Biopharm Latest Developments
 Table 105. CBL Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 106. CBL Peptide Drug CDMO Product Offered
 Table 107. CBL Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 108. CBL Main Business
 Table 109. CBL Latest Developments
 Table 110. Piramal Pharma Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 111. Piramal Pharma Peptide Drug CDMO Product Offered
 Table 112. Piramal Pharma Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 113. Piramal Pharma Main Business
 Table 114. Piramal Pharma Latest Developments
 Table 115. CPC Scientific Details, Company Type, Peptide Drug CDMO Area Served and Its Competitors
 Table 116. CPC Scientific Peptide Drug CDMO Product Offered
 Table 117. CPC Scientific Peptide Drug CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 118. CPC Scientific Main Business
 Table 119. CPC Scientific Latest Developments


List of Figures
 Figure 1. Peptide Drug CDMO Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Peptide Drug CDMO Market Size Growth Rate 2019-2030 ($ millions)
 Figure 6. Peptide Drug CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
 Figure 7. Peptide Drug CDMO Sales Market Share by Country/Region (2023)
 Figure 8. Peptide Drug CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
 Figure 9. Global Peptide Drug CDMO Market Size Market Share by Type in 2023
 Figure 10. Peptide Drug CDMO in Antineoplastic Drugs
 Figure 11. Global Peptide Drug CDMO Market: Antineoplastic Drugs (2019-2024) & ($ millions)
 Figure 12. Peptide Drug CDMO in Geno-Urinary System and Sex Hormones
 Figure 13. Global Peptide Drug CDMO Market: Geno-Urinary System and Sex Hormones (2019-2024) & ($ millions)
 Figure 14. Peptide Drug CDMO in Cardiovascular System Drugs
 Figure 15. Global Peptide Drug CDMO Market: Cardiovascular System Drugs (2019-2024) & ($ millions)
 Figure 16. Peptide Drug CDMO in Anti-Infective Drugs
 Figure 17. Global Peptide Drug CDMO Market: Anti-Infective Drugs (2019-2024) & ($ millions)
 Figure 18. Global Peptide Drug CDMO Market Size Market Share by Application in 2023
 Figure 19. Global Peptide Drug CDMO Revenue Market Share by Player in 2023
 Figure 20. Global Peptide Drug CDMO Market Size Market Share by Region (2019-2024)
 Figure 21. Americas Peptide Drug CDMO Market Size 2019-2024 ($ millions)
 Figure 22. APAC Peptide Drug CDMO Market Size 2019-2024 ($ millions)
 Figure 23. Europe Peptide Drug CDMO Market Size 2019-2024 ($ millions)
 Figure 24. Middle East & Africa Peptide Drug CDMO Market Size 2019-2024 ($ millions)
 Figure 25. Americas Peptide Drug CDMO Value Market Share by Country in 2023
 Figure 26. United States Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 27. Canada Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 28. Mexico Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 29. Brazil Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 30. APAC Peptide Drug CDMO Market Size Market Share by Region in 2023
 Figure 31. APAC Peptide Drug CDMO Market Size Market Share by Type (2019-2024)
 Figure 32. APAC Peptide Drug CDMO Market Size Market Share by Application (2019-2024)
 Figure 33. China Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 34. Japan Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 35. South Korea Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 36. Southeast Asia Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 37. India Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 38. Australia Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 39. Europe Peptide Drug CDMO Market Size Market Share by Country in 2023
 Figure 40. Europe Peptide Drug CDMO Market Size Market Share by Type (2019-2024)
 Figure 41. Europe Peptide Drug CDMO Market Size Market Share by Application (2019-2024)
 Figure 42. Germany Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 43. France Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 44. UK Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 45. Italy Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 46. Russia Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 47. Middle East & Africa Peptide Drug CDMO Market Size Market Share by Region (2019-2024)
 Figure 48. Middle East & Africa Peptide Drug CDMO Market Size Market Share by Type (2019-2024)
 Figure 49. Middle East & Africa Peptide Drug CDMO Market Size Market Share by Application (2019-2024)
 Figure 50. Egypt Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 51. South Africa Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 52. Israel Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 53. Turkey Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 54. GCC Countries Peptide Drug CDMO Market Size Growth 2019-2024 ($ millions)
 Figure 55. Americas Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 56. APAC Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 57. Europe Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 58. Middle East & Africa Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 59. United States Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 60. Canada Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 61. Mexico Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 62. Brazil Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 63. China Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 64. Japan Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 65. Korea Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 66. Southeast Asia Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 67. India Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 68. Australia Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 69. Germany Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 70. France Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 71. UK Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 72. Italy Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 73. Russia Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 74. Egypt Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 75. South Africa Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 76. Israel Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 77. Turkey Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 78. GCC Countries Peptide Drug CDMO Market Size 2025-2030 ($ millions)
 Figure 79. Global Peptide Drug CDMO Market Size Market Share Forecast by Type (2025-2030)
 Figure 80. Global Peptide Drug CDMO Market Size Market Share Forecast by Application (2025-2030)

Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape